|| Print ||
|Articles - May 2013|
|Monday, April 29, 2013|
BY PETER BARNES
A South Carolina native, biologist Jennifer Fox, Ph.D., followed research opportunities to Tulane University, Northwestern and, eventually, the University of Oregon, where her work focused on drug resistance in breast cancer. In 2008 she moved to the Oregon Translational Research and Development Institute (OTRADI), a nonprofit that helps scientists fund and execute advanced bioscience research. Now, as OTRADI’s new executive director, 39-year-old Fox will oversee a 13,000-square-foot business incubator hosting startups like Aronora, a researcher of cardiovascular drugs, and AbSci, which is developing an antibody production technology. Oregon Business caught up with Fox as the organization prepared to move into its new space in Portland’s South Waterfront district. There OTRADI hopes to entice more venture capital in a sector known for its robust growth and high-paying jobs.
OB: Commercial real estate firm Jones Lang LaSalle recently ranked U.S. regions with the largest bioscience presence. Seattle came in 10th. No Oregon city made the list. What makes Portland a good place for investment in this field?
Major research universities and talent. We have a place like OHSU that’s one of the largest employers in Portland and has a great deal of grant funding for research products. If we don’t create the kind of ecosystem that fosters that and keeps that within the state, we see what’s happened in the past — a product gets to a certain stage and then gets pulled down to California or up to Seattle.
OB: Why is that?
It takes so long for them to get products through the FDA approval process — about 12 years from start to stop to get from an idea to a drug stage, and they say $30 million on average. A lot of times companies — Aronora is a good example — get a product to a certain position by writing their own grants. But you get to the stage they call the “valley of death,” where you need a great deal more money and deeper pockets to get the drug all the way through the approval process. That’s when you partner with, perhaps, a larger company. That’s something we can help them do as well.
OB: Other industries already benefit from business accelerators hosted by Oregon universities, nonprofits and even Nike. What other resources unique to bioscience companies will OTRADI offer?
Our incubator is going to have specialized equipment for bioscience, which is cost limiting to a small bioscience company. You’re not going to want to build out your own laboratory with a fume hood and a tissue-culture hood and giant robots and machinery that you might need to get the work done. We will have that available in the shared facility, and have people here with the expertise to teach people how to use these pieces of equipment.
OB: What supporting industries could also benefit from a growing bioscience cluster?
In Oregon people would say our main strength is medical-device technologies or diagnostics. And those aren’t pharmaceutical drugs; those are actual you-can-put-your-hands-on-them products. So you could have materials. You could have medicinal chemistry. You’ve got companies across the state that are working on the reagents and the ingredients that scientists use to promote their research, and they like to be near companies that are engaged in this.
OB: Do you ever miss working in the lab now that you’re surrounded by emerging companies and promising research?
I do miss my research. But the great thing about working at OTRADI is having a new line on different topics and different areas all the time. Someone might come in who’s interested in cancer, or hormone signaling, or endocrine disruption, or anything that I’ve done in my past, and it’s great. But someone might come in with something completely new. It’s a challenge and it’s been great. It’s never boring.
Friday, June 06, 2014
BY KATIE AUSBURGER | OB GUEST CONTRIBUTOR
How to build a hipster-friendly work environment.
Thursday, July 24, 2014
BY LINDA BAKER | OB EDITOR
Remember the naysayers? Those who called the South Waterfront aerial tram a boondoggle? Those who rejoiced at the massive sell off of luxury condos at the John Ross and Atwater Place?
Thursday, June 12, 2014
BY ANDREA DURBIN | OB GUEST BLOGGER
Last week, the Obama administration took an important and welcomed step in the effort to protect the health and well-being of all Oregonians by limiting carbon pollution from existing power plants.
Tuesday, July 01, 2014
BY HANNAH WALLACE | OB BLOGGER
Demand for organic food continues to soar: Last year, sales of organic food rose to $32.3 billion — up 10% from 2012. In Oregon, organic produce wholesaler Organically Grown Co. has been championing organic growing methods for four decades.
Monday, July 14, 2014
BY VIVIAN MCINERNY | OB BLOGGER
Some people think Amazon’s winking eye logo is starting to look like a hoodwink.
Monday, July 07, 2014
BY TOM COX | OB BLOGGER
Named after the 2010 experiment by Thomas Ryan, "Robin Sages" are fake social media profiles designed to encourage linking and divulging valuable information.
Friday, July 18, 2014
BY JASON NORRIS | OB GUEST CONTRIBUTOR
Back in May, we shared a common Wall Street quote about investing, “Sell in May and go away.” Fast forward to July and the most common question we have been getting from clients is, “When is the market pullback going to occur?”
|The Private 150: Bigger But Leaner|
|The Perfect Food|
|Taxis Uber Alles?|
|Powerlist: Staffing Firms|
|Zillow to acquire Trulia for $3.5B|
|Dollar Tree to buy Family Dollar|
|Facebook revenue surges 61%|
|Walmart unexpectedly fires CEO|
|GM profit declines 80%|
|Study: Dogs can feel jealousy|
|Boeing profit surges 52%|
Vigilant enters a New Year with a new president.
How George Fox has become one of Oregon's largest private universities.
Forest Grove sees growth in the burgeoning food and beverage scene.
Lane Powell Shareholder Susan K. Eggum has been elected as vice chair of programs and projects for the International Association of Defense Counsel’s (IADC’s) Employment Law Committee.
Geffen Mesher is saddened to announce the passing of long-time shareholder, Tom “Mike” Anderson, who died on July 10, 2014, from liver disease diagnosed after recent heart surgery. He was 55 years old.
Fifteen Lane Powell attorneys have been named 2014 “Oregon Super Lawyers,” and another five attorneys have been named as “Oregon Rising Stars” by Super Lawyers magazine.